What's Happening?
Doximity, a digital platform for U.S. medical professionals, has acquired Pathway Medical Inc., a Montreal-based startup specializing in medical AI and evidence-based clinical reference. The acquisition, valued at $26 million in cash with up to an additional $37 million in equity grants, closed on July 29, 2025. Pathway Medical has developed one of the largest structured datasets in medicine, which is purpose-built for AI and covers nearly every medical guideline, drug, and landmark trial across all major specialties. This dataset has enabled Pathway's AI model to achieve a record-breaking 96% on the U.S. Medical Licensing Examination benchmark. The merger aims to democratize access to these advanced clinical tools by integrating Pathway's technology into Doximity's platform, which includes over 80% of U.S. physicians.
AD
Why It's Important?
The acquisition is significant as it addresses the growing need for clinical tools that combine trusted, evidence-based information with the speed and adaptability of AI. By integrating Pathway's AI into Doximity's vast network, the platform will empower an enormous user base with instant, evidence-based answers to medical questions, enhancing productivity and patient care. This move is expected to elevate Doximity's clinical reference capabilities, providing U.S. physicians with cutting-edge resources at the point of care. The integration of AI-driven tools is poised to improve healthcare delivery and outcomes, benefiting both medical professionals and patients.
What's Next?
The integration of Pathway's technology into Doximity's platform is expected to be seamless, providing millions of physicians with free access to advanced clinical tools. This strategic move may prompt other healthcare platforms to explore similar acquisitions to enhance their offerings. As AI continues to evolve, the healthcare industry may see further advancements in clinical accuracy and efficiency, potentially leading to improved patient outcomes and reduced healthcare costs.
